From bench to bedside: the history and progress of CAR T cell therapy
Chimeric antigen receptor (CAR) T cell therapy represents a major breakthrough in cancer
care since the approval of tisagenlecleucel by the Food and Drug Administration in 2017 for …
care since the approval of tisagenlecleucel by the Food and Drug Administration in 2017 for …
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of …
Graft-versus-host disease (GVHD) is a major factor contributing to mortality and morbidity
after allogeneic stem-cell transplantation. Because of the small number of results from well …
after allogeneic stem-cell transplantation. Because of the small number of results from well …
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
D Niederwieser, H Baldomero, N Bazuaye… - …, 2021 - pmc.ncbi.nlm.nih.gov
The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the mission
of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities …
of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities …
Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes
BL Scott, MC Pasquini, BR Logan, J Wu… - Journal of Clinical …, 2017 - ascopubs.org
Purpose The optimal regimen intensity before allogeneic hematopoietic cell transplantation
(HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with …
(HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with …
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
B Gyurkocza, BM Sandmaier - Blood, The Journal of the …, 2014 - ashpublications.org
An essential component of allogeneic and autologous hematopoietic cell transplantation
(HCT) is the conditioning regimen administered before the hematopoietic cell infusion. Early …
(HCT) is the conditioning regimen administered before the hematopoietic cell infusion. Early …
Hematopoietic stem cell transplantation for patients with AML in first complete remission
JJ Cornelissen, D Blaise - Blood, The Journal of the American …, 2016 - ashpublications.org
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of
continuing chemotherapy or transplantation using either autologous or allogeneic stem …
continuing chemotherapy or transplantation using either autologous or allogeneic stem …
Adoptive cellular therapy: a race to the finish line
Adoptive T cell transfer for cancer, chronic infection, and autoimmunity is an emerging field
that shows promise in recent trials. Using the principles of synthetic biology, advances in cell …
that shows promise in recent trials. Using the principles of synthetic biology, advances in cell …
Oral complications of cancer and cancer therapy: from cancer treatment to survivorship
JB Epstein, J Thariat, RJ Bensadoun… - CA: a cancer journal …, 2012 - Wiley Online Library
Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer
therapies cause acute and late toxicities that may be underreported, underrecognized, and …
therapies cause acute and late toxicities that may be underreported, underrecognized, and …
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
In this study, we evaluated trends and outcomes of allogeneic hematopoietic cell
transplantation (HCT) in adults≥ 70 years with hematologic malignancies across the United …
transplantation (HCT) in adults≥ 70 years with hematologic malignancies across the United …
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting
outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT) …
outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT) …